Mark Harber

1.9k total citations
53 papers, 888 citations indexed

About

Mark Harber is a scholar working on Epidemiology, Transplantation and Infectious Diseases. According to data from OpenAlex, Mark Harber has authored 53 papers receiving a total of 888 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Epidemiology, 14 papers in Transplantation and 9 papers in Infectious Diseases. Recurrent topics in Mark Harber's work include Renal Transplantation Outcomes and Treatments (14 papers), Cytomegalovirus and herpesvirus research (9 papers) and Herpesvirus Infections and Treatments (6 papers). Mark Harber is often cited by papers focused on Renal Transplantation Outcomes and Treatments (14 papers), Cytomegalovirus and herpesvirus research (9 papers) and Herpesvirus Infections and Treatments (6 papers). Mark Harber collaborates with scholars based in United Kingdom, Egypt and United States. Mark Harber's co-authors include Claire Atkinson, Colette Smith, Paul Griffiths, Douglas Thorburn, A. Burns, Vincent C. Emery, James O’Beirne, P. Sweny, Sowsan Atabani and Gareth Jones and has published in prestigious journals such as The Lancet, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Mark Harber

51 papers receiving 880 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mark Harber United Kingdom 19 352 182 174 150 142 53 888
T. Ben Abdallah Tunisia 16 246 0.7× 147 0.8× 100 0.6× 139 0.9× 192 1.4× 198 1.0k
Ahmed Halawa United Kingdom 14 171 0.5× 266 1.5× 180 1.0× 117 0.8× 87 0.6× 85 782
Priya S. Verghese United States 15 160 0.5× 259 1.4× 129 0.7× 107 0.7× 111 0.8× 56 842
Alden Doyle United States 17 299 0.8× 388 2.1× 143 0.8× 180 1.2× 133 0.9× 51 1.0k
M.R.N. Nampoory Kuwait 16 273 0.8× 140 0.8× 164 0.9× 118 0.8× 54 0.4× 49 692
Britta Höcker Germany 20 220 0.6× 503 2.8× 136 0.8× 161 1.1× 72 0.5× 54 934
E. Abderrahim Tunisia 15 132 0.4× 192 1.1× 108 0.6× 143 1.0× 97 0.7× 135 802
E. Renoult France 19 218 0.6× 282 1.5× 104 0.6× 195 1.3× 106 0.7× 67 1.1k
Elizete Keitel Brazil 16 170 0.5× 323 1.8× 97 0.6× 113 0.8× 54 0.4× 97 829
Marie Béatrice Nogier France 12 142 0.4× 256 1.4× 338 1.9× 124 0.8× 65 0.5× 15 904

Countries citing papers authored by Mark Harber

Since Specialization
Citations

This map shows the geographic impact of Mark Harber's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark Harber with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark Harber more than expected).

Fields of papers citing papers by Mark Harber

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark Harber. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark Harber. The network helps show where Mark Harber may publish in the future.

Co-authorship network of co-authors of Mark Harber

This figure shows the co-authorship network connecting the top 25 collaborators of Mark Harber. A scholar is included among the top collaborators of Mark Harber based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark Harber. Mark Harber is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Alshaer, Inji, Rachel Hung, Gareth Jones, et al.. (2025). Older Kidney Transplant Patients Are Over Immunosuppressed Using Standard Protocols With Differential Sex‐Based Complications. Journal of Transplantation. 2025(1). 5547629–5547629.
2.
Venturini, Cristina, Julia Colston, Oscar Charles, et al.. (2024). Persistent Low-Level Variants in a Subset of Viral Genes Are Highly Predictive of Poor Outcome in Immunocompromised Patients With Cytomegalovirus Infection. The Journal of Infectious Diseases. 230(2). e427–e436. 1 indexed citations
3.
Harber, Mark, et al.. (2024). Optimising Diabetes Care for Kidney Transplant Recipients. 11(1). 1–2. 1 indexed citations
4.
Chong, Stephanie, Rachel Hung, Fan‐Chi Chang, et al.. (2024). Composition of the neutralising antibody response predicts risk of BK virus DNAaemia in recipients of kidney transplants. EBioMedicine. 110. 105430–105430. 1 indexed citations
5.
Cherukuri, Aravind, Alan D. Salama, Rajil Mehta, et al.. (2021). Transitional B cell cytokines predict renal allograft outcomes. Science Translational Medicine. 13(582). 31 indexed citations
6.
Hung, Rachel, Lucy Campbell, Kate Bramham, et al.. (2021). The epidemiology of kidney disease in people of African ancestry with HIV in the UK. EClinicalMedicine. 38. 101006–101006. 15 indexed citations
7.
Willis, Joanna, Moji Awogbade, Jo Howard, et al.. (2020). Outcomes following kidney transplantation in patients with sickle cell disease: The impact of automated exchange blood transfusion. PLoS ONE. 15(8). e0236998–e0236998. 11 indexed citations
8.
Stern, Edward P., Sandra G. Guerra, Markella Ponticos, et al.. (2020). Analysis of Anti-RNA Polymerase III Antibody-positive Systemic Sclerosis and Altered GPATCH2L and CTNND2 Expression in Scleroderma Renal Crisis. The Journal of Rheumatology. 47(11). 1668–1677. 15 indexed citations
10.
Ong, et al.. (2017). UK Scleroderma Study Group (UKSSG) guidelines on the diagnosis and management of scleroderma renal crisis.. PubMed. 34 Suppl 100(5). 106–109. 28 indexed citations
11.
Thomas, Niclas, Sarita Workman, Lyn Ambrose, et al.. (2016). PD1-Expressing T Cell Subsets Modify the Rejection Risk in Renal Transplant Patients. Frontiers in Immunology. 7. 126–126. 21 indexed citations
12.
Harber, Mark, Sanjay Bhagani, Jeremy Levy, et al.. (2015). Impact of Tacrolimus Compared With Cyclosporin on the Incidence of Acute Allograft Rejection in Human Immunodeficiency Virus–Positive Kidney Transplant Recipients. Transplantation. 100(4). 871–878. 25 indexed citations
13.
Prendecki, Maria, et al.. (2015). Improving outcomes in patients with Acute Kidney Injury: the impact of hospital based automated AKI alerts. Postgraduate Medical Journal. 92(1083). 9–13. 27 indexed citations
14.
Hopkins, Susan, et al.. (2014). Managing latent tuberculosis in UK renal transplant units: how does practice compare with published guidance?. Clinical Medicine. 14(1). 26–29. 5 indexed citations
15.
Atabani, Sowsan, Colette Smith, Claire Atkinson, et al.. (2012). Cytomegalovirus Replication Kinetics in Solid Organ Transplant Recipients Managed by Preemptive Therapy. American Journal of Transplantation. 12(9). 2457–2464. 149 indexed citations
16.
Pinney, Jennifer H., et al.. (2011). Fulminant hepatitis following primary herpes simplex virus infection in renal transplant recipients. SHILAP Revista de lepidopterología. 22(1). 107. 7 indexed citations
17.
OʼRourke, Edward J., Christopher Laing, Aakif Ullah Khan, et al.. (2008). The Case ∣ Allograft dysfunction in a patient with sickle cell disease. Kidney International. 74(9). 1219–1220. 6 indexed citations
18.
Jones, Gareth, Maciej Juszczak, Edward Kingdon, et al.. (2004). Treatment of idiopathic membranoproliferative glomerulonephritis with mycophenolate mofetil and steroids. Nephrology Dialysis Transplantation. 19(12). 3160–3164. 28 indexed citations
19.
Harber, Mark, Anette Sundstedt, & David C. Wraith. (2000). The role of cytokines in immunological tolerance: potential for therapy. Expert Reviews in Molecular Medicine. 2(9). 1–20. 32 indexed citations
20.
Harber, Mark, et al.. (1994). Restoration of peritoneal lymphatic drainage leading to spontaneous resolution of haemodialysis ascites. Nephrology Dialysis Transplantation. 9(6). 716–717. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026